Cellectis (CLLS) Operating Expenses: 2013-2022
Historic Operating Expenses for Cellectis (CLLS) over the last 10 years, with Dec 2022 value amounting to $115.4 million.
- Cellectis' Operating Expenses rose 23.67% to -$22.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$97.9 million, marking a year-over-year increase of 23.85%. This contributed to the annual value of $115.4 million for FY2022, which is 18.78% down from last year.
- Per Cellectis' latest filing, its Operating Expenses stood at $115.4 million for FY2022, which was down 18.78% from $142.1 million recorded in FY2021.
- In the past 5 years, Cellectis' Operating Expenses ranged from a high of $142.1 million in FY2021 and a low of -$146.5 million during FY2019.
- Over the past 3 years, Cellectis' median Operating Expenses value was $115.4 million (recorded in 2022), while the average stood at $119.8 million.
- Its Operating Expenses has fluctuated over the past 5 years, first tumbled by 215.82% in 2019, then spiked by 169.52% in 2020.
- Cellectis' Operating Expenses (Yearly) stood at $126.5 million in 2018, then crashed by 215.82% to -$146.5 million in 2019, then skyrocketed by 169.52% to $101.9 million in 2020, then spiked by 39.46% to $142.1 million in 2021, then dropped by 18.78% to $115.4 million in 2022.